Gene · 7855
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions. | Cell | 2023 | 37562401 | PubTator, text mining | PubMed |
| S-acylation of the Wnt receptor Frizzled-5 by zDHHC5 controls its cellular localization and synaptogenic activity in the rodent hippocampus. | Dev Cell | 2023 | 37557176 | PubTator, text mining | PubMed |
| Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome. | Genes Dis | 2023 | 37554181 | PubTator, text mining | PubMed |
| A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression. | Front Oncol | 2023 | 37546393 | PubTator, text mining | PubMed |
| RA-induced prominence-specific response resulted in distinctive regulation of Wnt and osteogenesis. | Life Sci Alliance | 2023 | 37541848 | PubTator, text mining | PubMed |
| CCDC85A is regulated by miR-224-3p and augments cancer cell resistance to endoplasmic reticulum stress. | Front Oncol | 2023 | 37534255 | PubTator, text mining | PubMed |
| Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis. | Infect Immun | 2023 | 37530530 | PubTator, text mining | PubMed |
| Reactive Cutaneous Capillary Endothelial Proliferation Caused by Camrelizumab: Sixteen Case Reports. | Indian J Dermatol | 2023 | 37529461 | PubTator, text mining | PubMed |
| Targeted screening and identification of chlorhexidine as a pro-myogenic circadian clock activator. | Stem Cell Res Ther | 2023 | 37525228 | PubTator, text mining | PubMed |
| Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. | BMC Med Genomics | 2023 | 37525171 | PubTator, text mining | PubMed |
| Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations. | Nat Commun | 2023 | 37516754 | PubTator, text mining | PubMed |
| A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer. | Medicina (Kaunas) | 2023 | 37512088 | PubTator, text mining | PubMed |
| Senescence-Driven Inflammatory and Trophic Microenvironment Imprints Mesenchymal Stromal/Stem Cells in Osteoarthritic Patients. | Biomedicines | 2023 | 37509633 | PubTator, text mining | PubMed |
| Escin Activates Canonical Wnt/β-Catenin Signaling Pathway by Facilitating the Proteasomal Degradation of Glycogen Synthase Kinase-3β in Cultured Human Dermal Papilla Cells. | Curr Issues Mol Biol | 2023 | 37504289 | PubTator, text mining | PubMed |
| FGFR-mediated ERK1/2 signaling contributes to mesendoderm and definitive endoderm formation in vitro. | iScience | 2023 | 37502260 | PubTator, text mining | PubMed |
| A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT. | Cancer Gene Ther | 2023 | 37500894 | PubTator, text mining | PubMed |
| Role of Human Epicardial Adipose Tissue-Derived miR-92a-3p in Myocardial Redox State. | J Am Coll Cardiol | 2023 | 37468187 | PubTator, text mining | PubMed |
| Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma. | J Clin Med | 2023 | 37445475 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
| CircRNA: a rising star in leukemia. | PeerJ | 2023 | 37431465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7855/papers?page=8